The CMO/CDMO biotechnology market refers to the outsourcing of various biopharmaceutical manufacturing services to contract manufacturing organizations (CMOs) or contract development and manufacturing organizations (CDMOs). These organizations provide a range of services to biotechnology companies, including process development, scale-up, manufacturing, and packaging of various biologics, biosimilars, cell and gene therapies, and other products.
North America and Europe are currently the largest markets for CMO/CDMO biotechnology, owing to the presence of several established biotech companies and advanced healthcare infrastructure in these regions. However, the market is expected to see significant growth in Asia Pacific, due to the increasing focus on healthcare infrastructure development, as well as the growing demand for biopharmaceuticals in countries like China and India.
Some of the major players in the CMO/CDMO biotechnology market include Lonza, Catalent, Thermo Fisher Scientific, Patheon, WuXi AppTec, Samsung Biologics, and AbbVie Contract Manufacturing. These companies offer a range of services, including process development, manufacturing, analytical testing, and regulatory support, to cater to the needs of biotech companies of all sizes.
Competitive Landscape
Key players are concentrating on expansion in emerging regions and new revised product manufacturing. Market participants are also working to strengthen their expansion, new product launches, and improved distribution channels such as online sources of advertisement.
For instance:
For instance, Iovance Biotherapeutics chose Avid Bioservices in August 2020 to spearhead process development through cGMP manufacture of IOV-3001, an innovative anti-cancer medication candidate and new IL-2 analogue.
Fujifilm Diosynth Biotechnologies in April 2021, announced the establishment of its new Microbial production facility in the U.K. The aim of this expansion was to triple the existing microbial production. This new production facility was equipped with 2*2000L of fermenters and modular purification suits.